Price
Target price
€207.10
€207.10
2.320%
4.8
2.320%
€303.67
11.08.25 / Tradegate
WKN: 864330 / Symbol: WST / Name: West Pharmaceutical Services / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
West Pharmaceutical Services Inc. Stock
There is an upward development for West Pharmaceutical Services Inc. compared to yesterday, with an increase of €4.80 (2.320%).
With 8 Buy predictions and not the single Sell prediction the community is currently very high on West Pharmaceutical Services Inc..
As a result the target price of 303 € shows a positive potential of 46.31% compared to the current price of 207.1 € for West Pharmaceutical Services Inc..
Pros and Cons of West Pharmaceutical Services Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of West Pharmaceutical Services Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| West Pharmaceutical Services Inc. | 2.320% | 0.485% | 6.588% | -22.839% | -34.936% | -35.833% | -8.363% |
| Bio-Rad Labs Inc. A | -1.100% | -5.061% | 7.583% | -23.800% | -27.730% | -57.347% | -46.462% |
| Neogen Corp. | -0.930% | 7.882% | 2.817% | -70.993% | -63.500% | - | - |
| Haemonetics Corp. | -3.060% | -29.538% | -28.438% | -34.101% | -39.338% | -35.035% | -30.606% |
Comments
West Pharmaceutical Services, Inc. (NYSE: WST) had its price target raised by analysts at UBS Group AG from $285.00 to $320.00. They now have a "buy" rating on the stock.
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services, Inc. (NYSE: WST) had its price target raised by analysts at Evercore ISI from $275.00 to $350.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services, Inc. (NYSE: WST) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $275.00 price target on the stock.
Show more
Ratings data for WST provided by MarketBeat
News
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceuticals
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) and reminds
West Pharmaceutical Services Stock: Shares Plunge on Weak 2025 Outlook
West Pharmaceutical Services experienced a significant market setback as its stock touched a new 52-week low of $247.72 on Thursday, following the release of its 2025 guidance. The company's
